End-stage cardiomyopathy ventricular assist devices

Soon J. Park

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Heart disease is the number one cause of morbidity and mortality in Western society. This problem has become well recognized in the literature over the past few decades, and researchers have mounted intense efforts to remedy the situation. A heart transplant is clearly the most effective therapy for patients with advanced heart failure; it is able to restore them to a near-normal lifestyle, and long-term survival is excellent (1). However, the number of donor hearts available for transplantation is limited to only about 2000 each year, compared to over 10,000 people each year who could benefit from such a therapy.

Original languageEnglish (US)
Title of host publicationHandbook of Cardiac Anatomy, Physiology, and Devices
PublisherHumana Press
Pages421-426
Number of pages6
ISBN (Print)1588294439, 9781588294432
DOIs
StatePublished - Dec 1 2005

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'End-stage cardiomyopathy ventricular assist devices'. Together they form a unique fingerprint.

  • Cite this

    Park, S. J. (2005). End-stage cardiomyopathy ventricular assist devices. In Handbook of Cardiac Anatomy, Physiology, and Devices (pp. 421-426). Humana Press. https://doi.org/10.1007/978-1-59259-835-9_30